The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rifadin
rifampicin · Kit · Sanofi-Aventis U.S. LLC
NDC 00068-0660-50 · 1 KIT in 1 CARTON * 10 mL in 1 VIAL * 10 mL in 1 AMPULE · UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of rifampicin (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | Aug 7, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rifadin — NDC 00068-0660-50," retrieved September 3, 2026, https://drugdashboards.com/drug/00068066050.
Free to cite with attribution — see how the data is put together.